Hypertrophic And Keloid Scar Treatment Global Market is Booming Across the Globe and Witness Huge Growth By Key Players To 2033 | Lumenis Ltd., Enaltus LLC, Cynosure Inc., Alliance Pharma PLC, 3M Company

Overview and Scope
Hypertrophic and keloid scar treatment refers to the treatment of scars that do not grow beyond the boundaries of the original wound and spread to the surrounding skin. The hypertrophic scars are contained within the area of injury, while keloids spread outside the boundaries of the initial damage and do not regress.

Sizing and Forecast
The hypertrophic and keloid scar treatment market size has grown rapidly in recent years. It will grow from $6.91 billion in 2023 to $7.67 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%.  The  growth in the historic period can be attributed to risen incidence of hypertrophic and keloid scars, advancements in scar assessment, widespread adoption of topical treatments, surgical and invasive procedures, patient demand for scar improvement.

The hypertrophic and keloid scar treatment market size is expected to see strong growth in the next few years. It will grow to $11.14 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%.  The growth in the forecast period can be attributed to emerging minimally invasive interventions, advancements in scar revision techniques, growing interest in combination therapies, increasing awareness and early intervention, global aesthetic trends. Major trends in the forecast period include emerging injectable therapies, combination therapies for synergistic effects, patient-centric approaches, scar assessment technologies, telemedicine for follow-up and consultations.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/hypertrophic-and-keloid-scar-treatment-global-market-report

Segmentation & Regional Insights
The hypertrophic and keloid scar treatment market covered in this report is segmented –
1) By Treatment: Cryotherapy, Surgical Excision, Pressure Dressings, Intralesional 5-Fluorouracil, Superficial X-Ray, Intralesional Corticosteroid Injection, Other Treatments
2) By Products: Topical Products, Laser Products, Injectables, Other Products
3) By Scar: Hypertrophic Scars, Keloid Scars
4) By End-Use: Hospitals, Clinics, Other End-Users

North America was the largest region in the hypertrophic and keloid scar treatment market in 2023. Asia-pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10692&type=smp

Major Driver Impacting Market Growth
An increase in the number of road accidents and burn cases is expected to propel the growth of the hypertrophic and keloid scar treatment market going forward. Road accidents refer to an accident that occurs on the road and involves at least one vehicle and people. Road accidents and burn cases require attention and appropriate measures to prevent them and provide effective treatment. Hypertrophic and keloid scar treatments are used to treat people who are injured in road accidents by lowering the scar’s height and tightness. An increase in road accidents and burn cases contributes to the growth of the hypertrophic and keloid scar treatment market. For instance, in August 2022, according to the National Highway Traffic Safety Administration, a US-based agency of the federal government, part of the Department of Transportation, in the first three months of 2022, around 9,560 persons died in motor vehicle traffic accidents, an increase of nearly 7% compared to the 8,935 fatalities for the same period in 2021. Further, the mortality rate rose from the predicted rate of 1.25 fatalities per 100 million vehicle miles in the first quarter of 2021 to 1.27 fatalities per 100 million vehicle miles in the first quarter of 2022. Therefore, the increase in the number of road accidents and burn cases will drive the hypertrophic and keloid scar treatment market.

Key Industry Players
Major companies operating in the hypertrophic and keloid scar treatment market report are Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Mylan N.V., Stratpharma AG, Revitol Corporation Inc., Quantum Health, Scarfade, Biodermis, Renovo Group plc, Mederma, Silagen

The hypertrophic and keloid scar treatment  market report table of contents includes:
1. Executive Summary

2. Hypertrophic And Keloid Scar Treatment Market Characteristics
3. Hypertrophic And Keloid Scar Treatment Market Trends And Strategies
4. Hypertrophic And Keloid Scar Treatment Market – Macro Economic Scenario
5. Global Hypertrophic And Keloid Scar Treatment Market Size and Growth

…..

32. Global Hypertrophic And Keloid Scar Treatment Market Competitive Benchmarking
33. Global Hypertrophic And Keloid Scar Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Hypertrophic And Keloid Scar Treatment Market
35. Hypertrophic And Keloid Scar Treatment Market Future Outlook and Potential Analysis
36. Appendix

Explore the trending research reports from TBRC:
https://topprnews.com/animal-health-market-share

https://topprnews.com/bioprocess-analyzers-market

https://topprnews.com/autonomous-boats-market-growth

https://goodprnews.com/airlines-market

https://goodprnews.com/a2-milk-market

https://goodprnews.com/5g-core-network-market

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info

Healthcare Blog: https://healthcareresearchreports.com

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model